CD1D and neoplasm: To elucidate whether the antitumor effect of WTMCGEP depends on CD8+ T cells, CD1d−/− mice fed with or without the WTMCGEP diet were treated with anti-CD8 monoclonal antibodies in vivo before and after tumor challenge.